SCHEMBL2016578

SCHEMBL2016578

CC(=O)NC1CCN(c2c(CCNc3ncnc4[nH]cnc34)cc(Cl)c3cccnc23)C1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 8/20 0.38
AKT1 P31749 2/20 0.38
STK4 Q13043 1/20 0.37
STK3 Q13188 1/20 0.37
LRRK2 Q5S007 1/20 0.37
SMO Q99835 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPC1 O15118 1/20 0.36
ALOX12 P18054 1/20 0.36
RAB9A P51151 1/20 0.36
NCOA1 Q15788 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
SMPD3 Q9NY59 1/20 0.35
AURKA O14965 2/20 0.35
AURKB Q96GD4 2/20 0.35
BTK Q06187 1/20 0.34
SUV39H2 Q9H5I1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2018209 0.93 BTK (0.36) CNR2AKT1L3MBTL1NPC1ALOX12
SCHEMBL2014688 0.93 NPC1 (0.37) L3MBTL1NPC1ALOX12RAB9ABTK
SCHEMBL2014572 0.88 AKT1 (0.38) CNR2AKT1STK3SMOSUV39H2
SCHEMBL2014980 0.87 SLC40A1 (0.38) CNR2STK4STK3LRRK2L3MBTL1
SCHEMBL2014977 0.87 SLC40A1 (0.38) CNR2STK4STK3LRRK2L3MBTL1
SCHEMBL2017050 0.86 SLC40A1 (0.40) STK4STK3LRRK2L3MBTL1NPC1
Trifluoroacetic Acid SCHEMBL2013515 0.84 SLC40A1 (0.36) L3MBTL1RAB9AAURKAAURKB
SCHEMBL2016572 0.84 NPC1 (0.42) CNR2AKT1STK4STK3LRRK2
SCHEMBL2015211 0.84 AXL (0.32) L3MBTL1RAB9A
SCHEMBL2013328 0.84 L3MBTL1 (0.45) CNR2SMOL3MBTL1NPC1ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 WO claimed
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 WO disclosed